Search research articles
Contact Us
Filters
Showing results (111-120 of 155) with videos related to
Page
of 16
Sort By:
Cancer Epidemiology
|
June 28, 2020
Socioeconomic and administrative factors associated with treatment delay of esophageal and gastric carcinoma: Prospective study from a tertiary care centre in a developing country
D Lokanatha, Syed Adil Hassan, Linu Abraham Jacob, et al.
Chemotherapy Research and Practice
|
March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
October 29, 2024
Unmasking Infection Risks in Multiple Myeloma: Insights from a Retrospective Analysis
Linu Abraham Jacob, Sabeena K Choudhary, M C Suresh Babu, et al.
Antiviral Research
|
October 20, 2023
ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2
Wael L Demian, Rajesh Abraham Jacob, Olga Cormier, et al.
Cancer Research
|
November 16, 2012
Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth
Sarah S Burns, Elena M Akhmametyeva, Janet L Oblinger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 11, 2009
Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
Tina X Lee, Mark D Packer, Jie Huang, et al.
Breast Disease
|
August 23, 2021
Discordance in clinical versus pathological staging in breast cancer: Are we undermining the significance of accurate preoperative staging in the present era?
Shina Goyal, Linu Abraham Jacob, D Lokanatha, et al.
Indian Journal of Cancer
|
December 5, 2017
Multiple myeloma: Experience of an institute in limited resource setting
Linu Abraham Jacob, M C Suresh Babu, K C Lakshmaiah, et al.
Lung India : Official Organ of Indian Chest Society
|
November 6, 2020
Primary mucinous carcinomas of the lung: Clinical characteristics and treatment outcomes
L K Rajeev, Antony George Francis Thottian, Usha Amirtham, et al.
Frontiers in Immunology
|
November 16, 2020
Efferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
Charles Yin, Angela M Vrieze, Mara Rosoga, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 155) with videos related to
Sort By:
Page
of 16
Cancer Epidemiology
|
June 28, 2020
Socioeconomic and administrative factors associated with treatment delay of esophageal and gastric carcinoma: Prospective study from a tertiary care centre in a developing country
D Lokanatha, Syed Adil Hassan, Linu Abraham Jacob, et al.
Chemotherapy Research and Practice
|
March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
October 29, 2024
Unmasking Infection Risks in Multiple Myeloma: Insights from a Retrospective Analysis
Linu Abraham Jacob, Sabeena K Choudhary, M C Suresh Babu, et al.
Antiviral Research
|
October 20, 2023
ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2
Wael L Demian, Rajesh Abraham Jacob, Olga Cormier, et al.
Cancer Research
|
November 16, 2012
Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth
Sarah S Burns, Elena M Akhmametyeva, Janet L Oblinger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 11, 2009
Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
Tina X Lee, Mark D Packer, Jie Huang, et al.
Breast Disease
|
August 23, 2021
Discordance in clinical versus pathological staging in breast cancer: Are we undermining the significance of accurate preoperative staging in the present era?
Shina Goyal, Linu Abraham Jacob, D Lokanatha, et al.
Indian Journal of Cancer
|
December 5, 2017
Multiple myeloma: Experience of an institute in limited resource setting
Linu Abraham Jacob, M C Suresh Babu, K C Lakshmaiah, et al.
Lung India : Official Organ of Indian Chest Society
|
November 6, 2020
Primary mucinous carcinomas of the lung: Clinical characteristics and treatment outcomes
L K Rajeev, Antony George Francis Thottian, Usha Amirtham, et al.
Frontiers in Immunology
|
November 16, 2020
Efferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
Charles Yin, Angela M Vrieze, Mara Rosoga, et al.
Page
of 16